Background: Little is known about the long-term outcomes of severe acute respiratory
distress syndrome (ARDS) patients requiring extracorporeal membrane oxygenation …

Rationale: Because encouraging rates for hospital and long-term survival of
immunocompromised patients in ICUs have been described, these patients are more likely …

Background Based on promising results over the past 10 years, the method of
extracorporeal membrane oxygenation (ECMO) has developed from being used as a …

Background Extracorporeal membrane oxygenation (ECMO) is increasingly used to support
adults with severe respiratory failure refractory to conventional measures. In 2011, NHS …

Extracorporeal membrane oxygenation (ECMO) has been used for more than 50 years as
salvage therapy for patients with severe cardiopulmonary failure refractory to conventional …

Mechanical ventilation (MV) is a crucial element in the management of acute respiratory
distress syndrome (ARDS), because there is high level evidence that a low tidal volume of 6 …

Extracorporeal membrane oxygenation (ECMO) used for respiratory or cardiac support is
frequently considered a rescue therapy when ''conventional''management fails. Although the …

In theory, the application of extracorporeal membrane oxygenation (ECMO) in severe
respiratory failure allows lung treatments varying from a lung at rest (continuous positive …

Objectives: To evaluate the results of treatment of severe acute respiratory distress
syndrome (ARDS) with extracorporeal membrane oxygenation (ECMO), minimal sedation …

The influenza H1N1 epidemics in 2009 led a substantial number of people to develop
severe acute respiratory distress syndrome and refractory hypoxemia. In these patients …